1. Home
  2. INDV vs ECPG Comparison

INDV vs ECPG Comparison

Compare INDV & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDV
    SELLHOLDBUYas of 3 hours ago
  • ECPG
    SELLHOLDBUYas of 3 hours ago
  • Stock Information
  • Founded
  • INDV 1994
  • ECPG 1998
  • Country
  • INDV United States
  • ECPG United States
  • Employees
  • INDV N/A
  • ECPG N/A
  • Industry
  • INDV Biotechnology: Pharmaceutical Preparations
  • ECPG Finance Companies
  • Sector
  • INDV Health Care
  • ECPG Finance
  • Exchange
  • INDV Nasdaq
  • ECPG Nasdaq
  • Market Cap
  • INDV 1.2B
  • ECPG 1.2B
  • IPO Year
  • INDV N/A
  • ECPG 1999
  • Fundamental
  • Price
  • INDV $9.61
  • ECPG $35.40
  • Analyst Decision
  • INDV Strong Buy
  • ECPG Strong Buy
  • Analyst Count
  • INDV 2
  • ECPG 3
  • Target Price
  • INDV $14.50
  • ECPG $62.67
  • AVG Volume (30 Days)
  • INDV 1.2M
  • ECPG 350.4K
  • Earning Date
  • INDV 04-24-2025
  • ECPG 05-07-2025
  • Dividend Yield
  • INDV N/A
  • ECPG N/A
  • EPS Growth
  • INDV N/A
  • ECPG N/A
  • EPS
  • INDV N/A
  • ECPG N/A
  • Revenue
  • INDV $1,188,000,000.00
  • ECPG $1,316,361,000.00
  • Revenue This Year
  • INDV N/A
  • ECPG $21.62
  • Revenue Next Year
  • INDV $4.26
  • ECPG $10.12
  • P/E Ratio
  • INDV N/A
  • ECPG N/A
  • Revenue Growth
  • INDV 8.69
  • ECPG 7.66
  • 52 Week Low
  • INDV $7.33
  • ECPG $31.54
  • 52 Week High
  • INDV $22.53
  • ECPG $51.77
  • Technical
  • Relative Strength Index (RSI)
  • INDV 45.84
  • ECPG 39.03
  • Support Level
  • INDV $9.29
  • ECPG $33.55
  • Resistance Level
  • INDV $9.98
  • ECPG $36.68
  • Average True Range (ATR)
  • INDV 0.33
  • ECPG 1.30
  • MACD
  • INDV 0.01
  • ECPG 0.56
  • Stochastic Oscillator
  • INDV 29.21
  • ECPG 61.19

Stock Price Comparison Chart: INDV vs ECPG

INDV
ECPG
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April01020304050607080INDV VS ECPG

About INDV Indivior PLC

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.

About ECPG Encore Capital Group Inc

Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchase portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumer repay their obligations and work toward financial recovery. Encore has only a reportable segment being portfolio purchasing and recovery.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use